KOSDAQ large cap
Peptron
A biotech with long-acting peptide technology, developing platforms that extend dosing intervals for obesity and diabetes drugs. KOSDAQ large-cap constituent. Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.
087010.KQ Updated Jul 11, 2026 2 AI consumers· 2 recurring
Annual return · 2026-07-10'21-40.2%'22-6%'23+190.3%'24+304.6%'25+212.7%YTD-63.5%
Money in ▸·
Peptron
▸ Money out·
Financials & Segments
- Segments · Drug development (sustained-release peptides) · CDMO
Revenue from
No refined links yet.
Pays to
No refined links yet.